The merger of interventional device vendor Guidant of Indianapolis with healthcare products manufacturer Johnson & Johnson of New Brunswick, NJ, has been cleared by the European Commission, the firms reported.
In conjunction with the clearance, Johnson & Johnson has agreed to divest its Cordis Endovascular steerable guidewires business in Europe, as well as the Guidant Endovascular Solutions business in Europe. Johnson & Johnson said that remedies addressing overlap in the endoscopic vessel harvesting product lines are also being pursued with the European Commission.
The proposed transaction is also being reviewed by other regulatory authorities, including the Federal Trade Commission (FTC) in the U.S. Johnson & Johnson said it expects a decision by the FTC in October.
By AuntMinnie.com staff writers
August 25, 2005
Related Reading
Guidant notches sales record for Q2, July 21, 2005
Guidant to begin stent trial, May 5, 2005
Guidant shareholders OK acquisition, April 27, 2005
Guidant reports Q1 revenue growth, April 21, 2005
Verdicts come down in Medtronic/Guidant dispute, February 21, 2005
Copyright © 2005 AuntMinnie.com
